The global embolic protection devices market is expected to grow at a CAGR of 8.6% over 2022-2028. Rising demand for minimally invasive procedures, funding and investments for R&D on embolic protection devices, favorable reimbursement policies for these systems, growing burden of chronic diseases, consumer awareness regarding embolic devices, rise in number of trans-catheter aortic valve replacement (TAVR) procedures and technological advancements in embolic protection devices are some key factors fostering the market growth. However, factors such as stringent regulatory scenario, high cost of the devices and presence of alternative treatment are hindering the market growth. In addition, high growth in emerging economies provides huge growth opportunity for the market. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global market report include suppliers, manufacturers, marketers, policy makers, and service providers engaged in global embolic protection devices products.